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Background: Apoptosis is a major target and treatment effect of multiple chemotherapeutical agents in cancer.
A soybean isoflavone, genistein, is a well-studied chemopreventive agent and has been reported to potentiate the
anticancer effect of some chemotherapeutics. However, its mechanistic basis of chemo-enhancement effect
remains to be fully elucidated.
Methods: Apoptotic features of low concentration stressed cancer cells were studied by microscopic method,
western blot, immunostaining and annexin V/PI assay. Genistein’s effects on unstressed cells and recovering cells
were investigated using MTT cell viability assay and LDH cytotoxicity assay. Quantitative real-time PCR was
employed to analyze the possible gene targets involved in the recovery and genistein’s effect.
Results: Low-concentration ethanol stressed cancer cells showed apoptotic features and could recover after stress
removal. In stressed cells, genistein at sub-toxic dosage promoted the cell death. Quantitative real-time PCR
revealed the up-regulation of anti-apoptotic genes MDM2 and XIAP during the recovery process in HeLa cells, and
genistein treatment suppressed their expression. The application of genistein, MDM2 inhibitor and XIAP inhibitor to
the recovering HeLa cells caused persistent caspase activity and enhanced cell death. Flow cytometry study
indicated that genistein treatment could lead to persistent phosphatidylserine (PS) externalization and necrotic
events in the recovering HeLa cells. Caspase activity inhibition shifted the major effect of genistein to necrosis.
Conclusions: These results suggested two possible mechanisms through which genistein promoted cell death in
stressed cancer cells. Genistein could maintain the existing apoptotic signal to enhance apoptotic cell death. It
could also disrupt the recovering process in caspase-independent manner, which lead to necrotic events. These
effects may be related to the enhanced antitumor effect of chemotherapeutic drugs when they were combined
with genistein.
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Conventional chemotherapeutic agents were screened or
developed based on the feature that tumor cells usually
proliferate faster than normal cells [1,2]. By interacting
with different intracellular targets such as DNA molecules
or microtubules, chemotherapeutics introduce various
degrees of damage or stress in rapidly dividing cells,
leading to toxic effects [3,4]. Although the molecular* Correspondence: mingchiufung@cuhk.edu.hk
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reproduction in any medium, provided the ordetails responsible for their anti-cancer effects were not
fully unveiled, most anti-cancer drugs exert their toxicity
through apoptotic cell death [3-5]. The significance of
apoptosis in tumorigenesis and chemotherapy is further
underpinned by frequent mutations of genes involved in
apoptotic initiation and execution, and defects in apoptosis
may impair treatment effect [6,7]. The findings that
chemo-resistance of cancer cells is often associated with
defective apoptosis makes the restoration of effective
apoptosis a potential therapeutic improvement, either
through suppressing anti-apoptotic functions or restoring
the pro-apoptotic activities [8,9].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anti-cancer effects have been intensively studied. Epi-
demiological studies suggested that the lower incidence
of prostate and breast cancer in Asian, when compared
to western countries, could be attributed to the rich
isoflavonoid content found in Asian diets-including
genistein [10-12]. Both in vitro and in vivo analyses showed
that genistein inhibits the growth of various cancer cells at
doses non-toxic to normal cells [13-15]. In terms of its
known molecular targets in cancer cells, genistein was
proved to be a competitive inhibitor for estrogen receptor,
interfere signal transduction by inhibiting the activity of
protein tyrosine kinase, suppress angiogenesis, and arrest
cell cycle at G2-M transition [16-18]. The investigation
of gene expression profile of genistein-treated prostate
cancer cells also revealed that genistein could regulate the
expression of genes involved in various cell processes such
as proliferation, cell cycle progression, transcription, apop-
tosis, oncogenesis, angiogenesis, and cancer cell invasion
and metastasis [19,20]. Besides, increasing number of
research indicated that genistein promoted the anti-tumor
effect of chemotherapeutics towards multiple types of
tumors, implying that genistein could be a useful che-
mopreventive agent [21-23]. However, the mechanistic
basis for its chemo-enhancement effect remains to be fully
characterized.
In this study, we investigated the effect of genistein on
low concentration ethanol- stressed HeLa cells with
apoptotic features. Stressed HeLa cells could recover
after replacing the ethanol-containing medium with fresh
medium. We found that genistein promoted the cell death
of stressed HeLa cells at the concentration without detect-
able toxicity to untreated cells. The death-promoting
effect might result from the suppression of anti-apoptotic
genes includingMDM2 and XIAP, which were up-regulated
during recovery process after stress removal. Similar to
genistein’s effect, the inhibition of XIAP and MDM2
protein activity resulted in persistent caspase-3 activity
and enhanced cell death in the recovering HeLa cells.
Nevertheless, the application of caspases inhibitor did not
rescue the recovering cells from the death-promoting effect
of genistein. Collectively, our data provided evidence on the
death-potentiating effect of genistein on stressed HeLa cells
through caspase- dependent or independent way.
Results
Low concentration ethanol stressed HeLa cells displayed
apoptotic features and the stressed cell could recover
after stress removal
We initially aimed to set up stressed condition that
could initiate apoptotic features in HeLa cells. Ethanol-
induced hepatic apoptosis has been widely reported in
experimental trials with different animals and clinical
alcoholic diseases [24]. However, the toxic effects ofethanol correlate with the applied concentrations and
exposure time. High concentrations of ethanol could
cause necrotic cell death [25]. Low concentration ethanol
treatment was reported to induce apoptosis in HepG2
cells, and both fas- and cytochrome C-mediated pathway
may be involved [24,25]. In human intestinal Caco-2 cell
line, treatment with 10% ethanol up to 3 hours could lead
to considerable PS externalization. Caspase-mediated CK18
cleavage and DNA fragmentation was detected after
2 hours’ treatment [26].
We optimized the ethanol (stress) concentration and
exposure time used to stress HeLa cells. Incubation in
ethanol-containing medium (5.5% , V:V) up to 8 hours
(E8hrs) caused significant cellular shrinkage while the
shrunken cells regained normal morphology after
replacing stressed medium with fresh culture medium
(E8 hrs + R24 hrs) (Figure 1a). Nuclear condensation
and the disruption of mitochondrial network were ob-
served, which were reversible after the removal of stress
(Figure 1a).
In addition to morphological changes, biochemical
markers of apoptosis were investigated. Western blot and
caspase-3 immunostaining results showed the cleavage of
biochemical marker caspase-3 and its substrate PARP in
the stressed cells (Figure 1b, c: E6 hrs & E8 hrs). The acti-
vation of caspase-7 and −9 were also detected (Figure 1b).
The disappearance of cleaved caspases and PARP after
24 hours’ recovery (E8 hrs + R24 hrs) indicated that apop-
totic signals could be terminated and eliminated in the
absence of continuous stress. Furthermore, Annexin V
and PI staining assay revealed the loss of membrane
asymmetry after stress treatment in the form of phos-
phatidylserine (PS) externalization (Figure 2e, E8 hrs), and
the gradual restoration of membrane asymmetry after
stress removal (Figure 2e, E8 hrs + R12 hrs & E8 hrs +
R24 hrs). The gradual increase of annexin V signal in-
tensity with the ethanol stress time was consistent with
previous study concerning ethanol-induced apoptosis in
Caco-2 cells [26], which seems to be a concentration- and
time-dependent process. Collectively, our results demon-
strated the ethanol-stressed apoptotic features, including
morphological and biochemical alterations, were reversible
in HeLa cells. The optimized stress conditions (5.5%
ethanol 8 hrs for HeLa), on which most cells displayed
reversible changes, were used for the following study.
At sub-toxic concentration, genistein promoted the cell
death of stressed HeLa cells after the removal of ethanol
Based on the optimized stress conditions, we compared
the dose-responsive curves of genistein between stress
and unstressed cells using MTT assay. Stressed HeLa cells
were more sensitive to genistein treatment than unstressed
ones, manifested by the left shift of dose–response curve of
stressed group (Figure 2a, p < 0.01 by two-way ANOVA)
Figure 1 Low concentration ethanol stressed HeLa cells displayed apoptotic features but could recover after stress removal. (a). Live
cell imaging of HeLa cells before stress treatment (control), 5.5% ethanol stressed for 6 (E6 hrs) and 8 h (E8 hrs), and after stress removal for 24 h
(R24 hrs). Mitochondria (red, MitoTracker Red Staining) and Nuclei (blue, Hoechst 33342 staining) were visualized by fluorescence (Scale bar:
20 μm). (b). Western blot was used to detect the cleavage of PARP and caspase enzymes after stress treatment (E6 hrs & E8 hrs) and 24 h
recovery (E6 hrs + R24 hrs & E8 hrs + R24 hrs). (c). Immunostaining of cleaved caspase-3 of stressed (E) and recovered (E + R) HeLa cells. After
incubated with anti-cleaved caspase 3 antibody, the cells were further stained with Alexa Fluor® 488-conjugated secondary antibody. Nuclei were
stained with Hoechst 33342 and the cells were visualized with fluorescence microscopy (Scale bar: 100 μm).
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Figure 2 Genistein promoted cell death of stressed cancer cells at sub-toxic concentration to unstressed cells. (a). Dose-dependent
responsive curves of genistein on unstressed cells (G Alone) and stressed cells (E + G) of HeLa for 48 h treatment by MTT assay. Percentage of
inhibition was calculated as: [(mean value of untreated control – each value of G alone group)/ mean value of untreated control] x 100% for
Genistein Alone (G Alone) group; [(mean value of stressed + fresh medium (E + R) readings – each value of stressed + genistein (E + G) group)/
mean value of stressed + fresh medium (E + R) readings] x 100% for stressed + genistein (E + G) group. Two-way ANOVA was used to test the
significance of ethanol stress as the source of variance. (b). LDH cytotoxicity assay of genistein treatment on HeLa cell for 18 h. Upper figure: LDH
assay reading of dose-dependent genistein treatment: low control: untreated sample; High control: Triton X-100 treated. Bottom figure:
percentage of cytotoxicity of dose-dependent genistein treatment. (c). BrdU cellular proliferation assay of dose-dependent genistein treatment of
HeLa cells for 48 h. G stands for genistein. (d). Dose-dependent effects of genistein on untreated HeLa cell (upper figure) and ethanol-stressed
HeLa cells (E8 hrs + G24 hrs, lower figure) for 24 h. Cont’ E: continuous ethanol stress treatment; E8 hrs + R24 hrs: ethanol stressed for 8 h and
ethanol was replaced by fresh medium for 24 h recovery; Blank: DMSO solvent without genistein. (e). Annexin V and propidium iodide staining of
HeLa cells before (untreated) and after stress treatment (E8 hrs), and after the removal of stress (E8 hrs + RXhrs). Groups treated with genistein
(15 μg/ml) alone (G Alone) and the stressed groups treated with genistein (15 μg/ml) after stress removal (E8 hr + GXhrs) were included. Cont’ E
for continuous ethanol stress treatment group. The percentage of events of early apoptotic (lower right), and late apoptotic or necrotic
(upper right) is indicated in each diagram. (f). Morphological changes of HeLa cells after stress treatment (E8hrs), stress treatment and 24 h
recovery (E8 hrs + R24 hrs), and recovery in presence of genistein (15 μg/ml) (E8 hrs + G24 hrs) under inverted phase contrast microscope
(Scale bar: 10 μm). (g). Trypan blue dye exclusion assay of HeLa cells after stress treatment, stress treatment and 24 h recovery, and recovery in
presence of genistein (15 μg/ml). (Data points in above figures represent Mean ± SEM of three independent experiments; SEM = error bar;
* indicates: p < 0.05; ** indicates: p < 0.01).
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50% inhibitory effect: 48.55 μg/ml for unstressed cells;
10.53 μg/ml for stressed cells). To exclude the effect of
direct cytotoxicity and anti-proliferation of genistein, we
then detected the cytotoxic range of genistein by lactate
dehydrogenase release assay and its effective dose of
anti-proliferation effect by BrdU incorporation assay.
The death-promoting effect of genistein on stressed
HeLa cells existed at the concentration (10 μg/ml) where
there were no detectable cytotoxicity to unstressed group
(Genistein ≥ 25 μg/ml to be cytotoxic in HeLa cells) and
anti-proliferative effects (Genistein ≥ 15 μg/ml to show
detectable anti-proliferation effect in HeLa cells) (Figure 2b,
c, d). Below the threshold of cytotoxicity, 10 μg/ml genistein
treatment significantly reduced MTT reading of stressed
cells, compared to the MTT reading of stressed cells with
fresh medium replacement only (Figure 2d, p < 0.01).
We further applied Annexin-V and PI staining assay to
investigate genistein’s effect quantitatively. Flow cytome-
try results demonstrated that genistein treatment (at
concentration 15 μg/ml, no cytotoxicity effect) inhibited
the membrane asymmetry restoration of stressed cells
(E8 hrs + G12 hrs & E8 hrs + G24 hrs), while genistein
treatment on unstressed cells showed no significant
effect (G Alone 24 hrs) (Figure 2e). In the presence of
genistein (E8 hrs + G24 hrs), Annexin V single-positive
cells persisted and the percentage of Annexin V/PI
double-positive cells increased in the stressed cell popula-
tion, indicating pleiotropic effects of genistein on the re-
covery from stress. The cellular morphologies in
different experimental groups were showed in Figure 2f,
which was consistent with the flow cytometry data to
show the death-promoting effect of genistein on the
stressed cells. Trypan blue dye exclusion assay was used
to quantify the terminally dead cells which are permeableto the dye. The results further verified that the genistein
promoted the death of stressed cells which was undergo-
ing the recovery process (Figure 2g).
Genes involved in recovery of stress treatment were
influenced by genistein
To study the mechanism of the recovery from stress and
the death-promoting effect of genistein, we first compared
the sensitivity difference to transcription and translation
inhibitor (Actinomycin D and Cycloheximide) between
stress and unstressed HeLa cells. Dose-responsive curve
indicated stressed cells undergoing recovery process were
more sensitive to transcription and translation inhibition
(Figure 3a, p < 0.01 by two-way ANOVA). We then
collected mRNA samples of HeLa cells at different time
points after the removal of stress in the absence or presence
of genistein, including the group treated with genistein
alone (Figure 3b). Quantitative real-time PCR was applied
to determine the mRNA level of genes relevant to apoptosis
or survival. Among the genes investigated, ATF3, CREB1,
XIAP, MDM2 and MCL1 were involved in the recovery
period, which were up-regulated after the stress removal
and then gradually returned to the level of untreated
control (Figure 3c, statistical comparison of each time point
between Wash + Fresh Medium and Wash +Genistein
group by tow-way ANOVA, * indicates: p < 0.05;
** indicates: p < 0.01). Genistein treatment interfered with
the expression profiles of ATF3, XIAP, MDM2 and MCL1
genes during recovery phase. Genistein delayed the
decrease of ATF3 and MCL1 expression, but attenuated
up-regulation of XIAP andMDM2 in the group undergoing
recovery, while genistein treatment alone to unstressed
group did not have that effect (Figure 3c). Other genes
including TP53, NOXA, PUMA did not seem to be
regulated during the recovery period after stress removal.
Figure 3 (See legend on next page.)
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Figure 3 Genes involved in the recovery from stress treatment were influenced by genistein. (a). Dose-dependent responsive curves of
Actinomycin D and Cycloheximide on unstressed cells (ACD Alone and CHX Alone) and stressed cells (E8 hrs + ACD and E8 hrs + CHX) of HeLa for 48 h
treatment by MTT assay. Two-way ANOVA was used to test the significance of ethanol stress as the source of variance. IC50 of each group is
summarized in table. (b). Schematic schedule of RNA sample collection for each treatment group, including genistein treatment alone, stressed and
replaced with fresh medium for recovery, and stressed and replaced with genistein-containing medium. (c). Time-dependent gene expression profiles
of ATF3, CREB1, XIAP, MDM2, TP53, NOXA, PUMA, MCL1, BAX, BCL2, in different groups of HeLa cell. Control stands for the untreated cells; E8 hrs
represents ethanol-stressed cells for 8 hrs; Black line: ethanol-stressed and stress replaced with fresh medium; Orange line: ethanol-stressed and stress
replaced with medium containing 15 μg/ml genistein. Blue line: unstressed cells treated with 15 μg/ml genistein. Each gene expression level is
normalized to that of GAPDH. (Data point above is expressed as Mean ± SEM, n = 3; asterisk indicates statistical comparison of each time point
between Wash + Fresh Medium and Wash + Genistein group by tow-way ANOVA, * indicates: p < 0.05; ** indicates: p < 0.01).
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expression levels after the removal of stress. The third
group of genes such as BCL2 and BAX did not seem to
play significant part in the recovery and in the genistein
treatment group. Overall, the gene expression profiles
demonstrated differential gene expressions in the recovery
from stress treatment and the influence of genistein on their
regulations. XIAP and MDM2 genes, whose expressions
were up-regulated in the recovery process and attenuated
in the presence of genistein, were subject to further
investigation.
Similar to genistein, MDM2 and XIAP inhibitor potentiated
the cell death and caused persistent caspase-3 activity in
recovering cells
To confirm the roles of MDM2 and XIAP in the recovery
of stressed cells, we first compared the sensitivity of
stressed cells and unstressed cells to MDM2 inhibitor
(Boranyl-chalcone) and XIAP inhibitor (Embelin). IC50
difference (Figure 4a, table) indicated that HeLa cells
undergoing recovery are highly dependent on MDM2
and XIAP activity. XIAP and MDM2 inhibitor treatment
suppressed the regaining of normal morphology of stressed
cells after stress removal (Figure 4b). MTT and Trypan
blue assay demonstrated that XIAP and MDM2 inhibition
caused further loss of cellular viability and enhanced cell
death to the recovering cells at the concentration
where there were no significant effects to unstressed
cells (Figure 4c). More importantly, western blot and
immunostaining results revealed that after the removal of
stress, apoptotic marker like cleaved caspase 3 and PARP
persisted in the recovering HeLa cells in the presence of
genistein, XIAP and MDM2 inhibitor (Figure 4d, e). These
data suggested that genistein might enhance the cell death
of stressed HeLa cells by continuing the existing apoptotic
signal or by preventing the clearance of activated caspases,
possibly through the interference with MDM2 and XIAP
expression.
The death-promoting effect by genistein could be
caspase-independent
Now that apoptotic signal like cleaved caspase 3 persisted
in the recovering cells when genistein was present, wefurther applied general caspase inhibitor to investigate
whether the caspase activity inhibition could rescue
genistein’s death-enhancing effect on the stressed HeLa
cells. General caspase inhibitor Z-VAD-fmk effectively
blocked caspase activity at the concentration of 100 μM,
manifested by the great reduction of cleaved PARP
(Figure 5a). Through MTT viability assay, the addition
of Z-VAD-fmk did not rescue the death-promoting effects
of genistein on the recovering cells, which indicated that
genistein’s effect was not restricted to the enduring and
potentiation of apoptotic signal (Figure 5b).
Caspase inhibition shifted genistein’s action profile
Another question to be considered was what are other
factors contributing to genistein’s effect in the recovering
HeLa cells? Using Annexin V/PI staining assay, we observed
that caspase activity inhibition contributed little to the
recovery process after the stress removal (Figure 6c).
However, the addition of caspase inhibitor significantly
altered the profile of genistein’s effect by a great percentage
shift from Annexin V single positive cells to Annexin V/PI
double-positive cells after 24 hours (Figure 6c: E8 hrs +
G24 hrs & E8 hrs + G&Z-VAD24 hrs). These changes
were further manifested by the increase of cells displaying
necrotic features in the presence of both genistein and
Z-VAD-fmk (Figure 6a: E8 hrs +G&Z-VAD24 hrs), com-
pared to the group with genistein treatment only (Figure 6a:
E8 hrs + G24 hrs). Trypan blue staining showed consistent
result that significant increase of cells losing homeostasis
control in genistein treatment group in the presence of
caspase inhibitor Z-VAD-fmk (Figure 6b). Together, these
results implied that genistein could also influence other
cellular recovery processes and disrupt the homeostasis
maintenance of stressed cells to cause necrosis which is
secondary to the primary apoptotic program.
Discussion
Low concentration of ethanol has been reported to induce
apoptosis in animal and cell line models [24-26]. Ethanol-
inducible Cytochrome-P4502E1 (CYPE gene product)
may contribute to the death signal by producing reactive
oxygen species [27]. In this study, we optimized ethanol
treatment condition in HeLa cell line. We provided
Figure 4 (See legend on next page.)
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Figure 4 MDM2 and XIAP inhibitor potentiated the cell death and caused persistent caspase activity in stressed HeLa cell.
(a). Dose-dependent responsive curves of MDM2 inhibitor (Boranyl-chalcone) and XIAP inhibitor (Embelin) on unstressed cells (Inhibitor Alone)
and stressed cells (E8 hrs + Inhibitor) of HeLa for 48 h treatment by MTT assay. Two-way ANOVA was used to test the significance of ethanol stress as
the source of variance. IC50 of each group is summarized in table. (b). Morphology of HeLa cells recovered 24 h from stress (E8 hrs + R24 hrs) and
cells treated with MDM2 inhibitor (10 μM) or XIAP inhibitor (20 μM) for 24 h during recovery period (E8hrs + inhibitor 24 hrs). Inhibitor treatment
alone for 24 h was included (Scale bar: 10 μm). (c). Cell viability assay of the effects of MDM2 inhibitor (10 μM) or XIAP inhibitor (20 μM) on HeLa cells
undergoing recovery from stress treatment for 24 h treatment. Left: MTT cell viability assay; Right: Trypan blue dye exclusion assay (Mean ± SEM,
n = 3; ns indicates: no significance; ** indicates: p < 0.01). XIAPi stands for XIAP inhibitor; MDM2i stands for MDM2 inhibitor. (d) Western blot analysis
of the effects of genistein (15 μg/ml), MDM2 inhibitor (10 μM) and XIAP inhibitor (20 μM) 24 h treatment on HeLa cells undergoing stress recovery.
+E: 5.5% ethanol stress for 8 hrs followed by genistein and inhibitor treatment. -E: without ethanol stress treatment. (e). Immunostaining of cleaved
caspase-3 of stressed and unstressed HeLa cells treated with genistein (15 μg/ml), MDM2 inhibitor (10 μM) and XIAP inhibitor (20 μM). Cleaved
caspase-3 (Green) stained with Alexa Fluor® 488-conjugated antibody, Nuclei (Blue) stained with Hoechst 33342 (Scale bar: 100 μm).
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features including cell shrinkage, nucleus condensation,
PS externalization, mitochondrial disruption and dysfunc-
tion, and caspase activation (Figure 1 and Figure 2e),
which are characterized of apoptotic cell death [28-30].Figure 5 Caspase activity inhibition did not rescue the effects of geni
or unstressed with 5.5% ethanol for 8 h (E8 hrs), in the absence (−) or the p
-fmk, and the PARP cleavage was examined by Western blot. (b). MTT assay
the presence (+) of general caspase inhibitor Z-VAD-fmk (100 μM) for 24 h
of ethanol-containing medium (Data expressed as Mean ± SEM, n = 3; ns inOverall, the result that stressed HeLa cells showing
apoptotic features could recover after stress removal is
consistent with previous studies that loss of membrane
asymmetry in early apoptosis [31,32] and the activation
of caspase activity [33,34] by different apoptotic inducerstein’s effect on recovering HeLa cells. (a). HeLa cells were stressed
resence (+) of 25, 50, and 100 μM of general caspase inhibitor Z-VAD
about genistein’s effects on stressed HeLa cell, in the absence (−) or
. E 8 hrs stands for 8 h ethanol stress; Washing stands for the removal
dicates: no significance; ** indicates: p < 0.01).
Figure 6 (See legend on next page.)
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Figure 6 Caspase activity inhibition shifted the effects of genistein to secondary necrosis. (a). Morphology of HeLa cells undergoing the
recovery from stress treatment, in the presence of 100 μM Z-VAD-fmk (upper), or 15 μg/ml genistein (middle), or both (bottom) for 24 h. Arrows
indicate the cell swelling and membrane rupture of shrunk cells. (b). Trypan blue dye exclusion assay of HeLa cells after the removal of stress,
in the presence of 15 μg/ml genistein or 100 μM Z-VAD-fmk or both for 12 h and 24 h respectively (Data expressed as Mean ± SEM, n = 3;
** indicates: p < 0.01). (c). Annexin V and propidium iodide staining assay of HeLa cells after stress treatment and stress removal in the presence
of 15 μg/ml genistein or 100 μM Z-VAD-fmk or both for 12 h and 24 h respectively. (E + Z-VAD) 8 hrs stands for ethanol stress for 8 h in the
presence of Z-VAD. The percentage of events early apoptotic (lower right), and late apoptotic or necrotic (upper right) were indicated in
each diagram.
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characterized by time-lapse video microscopy in previous
study, which showed that apoptotic dying cancer cells
regained normal morphology and proliferate after the
removal of inducer [34]. The reversibility of cancer cell
from apoptosis raised interesting question whether
apoptotic recovery contributes to survival or repopulation
of cancer after cycles of chemotherapy.
Accumulating evidence suggested that cancer preventa-
tive agents might be combined with chemotherapy or
radiotherapy to enhance treatment outcome [23]. Soybean
isoflavone genistein is the one of the most widely studied
compound for its prominent anti-proliferation effects on
cancer cells [16,17]. In addition to its cytotoxicity and
anti-proliferation effect, we showed that genistein could
promote cell death of ethanol-stressed HeLa cells with
apoptotic features (Figure 2). As genistein was reported to
enhance the effects of anti-cancer drugs [16,17,21,22] and
anti-cancer agents could induce apoptosis in cancer cells
[3-5], the death-promoting effect of genistein on stressed
HeLa cells may at least partially contribute to enhanced
anti-tumor effect when it was combined with anti-cancer
drugs.
Our results also demonstrated that the recovering HeLa
cells were addicted to transcription and translation
processes (Figure 3a), implying that cells undergoing
recovery process were highly dependent on de novo
synthesis. As the cleavage of cellular proteins by activated
caspase is irreversible, it is anticipated that caspase activity
should be counteracted and the damaged cellular proteins
should be replenished if a cell is capable of recovering
from caspase-dependent apoptotic event [35]. In this view,
de novo synthesis may not only function to compensate
for cellular damages, but also to clear the caspase activity.
Our data showed the up-regulation of XIAP and MDM2
genes after the stress removal in HeLa cell (Figure 3c).
XIAP protein is a member of IAP (Inhibitors of Apoptosis
Proteins) family, which not only directly interacts with ac-
tivated caspases to block their activities but also functions
as E3 ubiquitin ligase to assist the ubiquitination of
activated caspases and their subsequent degradation
[36,37]. MDM2 is a well-documented ubiquitin ligase
binding to p53 to negatively regulate its stability andtranscriptional activity [38,39]. The up-regulation of
XIAP and MDM2 may function to eliminate the caspase
activity and terminate the p53-dependent apoptosis signal
after stress removal. Indeed, inhibiting MDM2 or XIAP
activity caused persistent caspase activity and enhanced
cell death (Figure 4). In addition, CREB1 gene that acts as
a transcription factor for other pro-survival genes [40,41]
was up-regulated during recovery phase (Figure 3c).
Together, our data supports the hypothesis that both
counter-apoptotic signals and pro-survivor signals are
involved in the recovery process from ethanol-induced
apoptotic events.
Genistein exerted obvious interference on the expression
profiles of ATF3, XIAP, MDM2, TP53, NOXA and PUMA
genes in HeLa cell (Figure 3c). ATF3 gene encodes a
rapidly-induced stress sensor that functions to stabilize p53
protein and contribute to the acceleration of pro-apoptotic
signal [42,43]. Our data showed that genistein treatment
delayed the down-regulation of ATF3 after the removal
of stress (Figure 3c). Together with attenuated MDM2
expression level, delayed down-regulation of ATF by genis-
tein may function to increase p53 level and the subsequent
trans-activation of p53 target genes NOXA and PUMA
(Figure 3c), which encode the pro-apoptotic proteins Noxa
and Puma [44,45]. Interestingly, genistein also delayed the
down-regulation of anti-apoptotic gene MCL1 (Figure 3c;
ref. [46]). However, this anti-apoptotic signal may be
rapidly overwhelmed by the up-regulation of NOXA and
PUMA genes.
Now that anti-apoptotic genes XIAP and MDM2 were
up-regulated during the recovery phase and genistein
suppressed their up-regulation (Figure 3c), and XIAP or
MDM2 inhibitor caused persistent caspase activity in
the recovering cells (Figure 4d, e), the death-enhancing
effects of genistein may result from the hindrance to the
termination of apoptotic effectors. However, the addition
of caspase inhibitor did not rescue the cells from
genistein’s inhibitory effects (Figure 5). Genistein together
with caspase inhibitor increased the percentage of necrotic
events in the cells recovering from apoptosis (Figure 6).
Previous studies have demonstrated that genistein could
suppress the AKT and NF-κB pro-survivor signaling
pathway in various type of cancer cells [21,47-49]. AKT-
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up-regulate anti-apoptotic genes like XIAP [50,51]. AKT
also functioned to activate and enhance MDM2 activity
[52,53]. Indeed, previous researchers have showed that
genistein down-regulated MDM2 at transcriptional and
post-translational level [54] and reduced XIAP protein
was detected following genistein treatment [55]. In this
view genistein’s death-promoting action on the cellular
recovery may result from both the persistent pro-apoptotic
signal and the impaired recovering processes due to the
impairment of pro-survival pathway in HeLa cell. However,
it remains to be clarified how the recovering cells diverted
the effect of genistein to necrotic death in the presence of
caspase inhibitor.
Collectively, on the basis of our results and previous
studies, we propose a hypothetic pathway through which
genistein may exert its death-promoting effect on the
stressed HeLa cells (Figure 7). Possibly through inhibiting
the activity of AKT and NF-κB, genistein suppresses the
up-regulation of XIAP andMDM2 that were showed to be
involved in the recovery process. Genistein treatment also
sustains ATF3 expression level after the removal of stress,
which together with decreasedMDM2 level contributes to
the stabilization of p53. p53 accumulation trans-activates
its target genes including NOXA and PUMA to cause
persistent pro-apoptotic signals. Since AKT pathway
functions to promote protein synthesis, regulate glucose
metabolism, suppress pro-apoptotic signal and activate
NF-κB [56,57], the attenuated AKT and NF-κB activity
due to genistein treatment may weaken the ability to
antagonize existing apoptotic effectors and impair the
recovery from the damages insulted by the stress.Figure 7 Schematic illustration of the mechanism of
genistein’s inhibition on the recovery from apoptotic event.
Black lines indicate pro-apoptotic signals; red lines indicate
pro-survival signals.Conclusions
In summary, this study revealed novel effects of genistein
on inhibiting the recovery of HeLa cells from apoptotic
events. This effect of genistein on other types of cancer
cells and related mechanisms remain to be elucidated,
and it is possible that this effect could account for the
enhanced anti-tumor effect when genistein is combined
with chemotherapeutic drugs. It is anticipated that the
discovery of more effective inhibitor of .apoptotic recovery
could help to improve chemotherapy.
Methods
Cell lines and cell culture
Human cervical cancer cells HeLa (from ATCC) was
cultured in DMEM (Dulbecco’s minimum essential
medium, Gibco). The medium was supplemented with
10% fetal bovine serum (Hyclone, Thermo Scientific),
100 U/ml penicillin and 100 μg/ml streptomycin (Gibco,
Carlsbad, CA, USA) at 37°C under humidified atmosphere
of 5% CO2/95% air. Cells were seeded on tissue culture
plates until cell density reached 60% to 70% confluence be-
fore being subjected to each experiment. The compounds
used for testing the death-promoting effect on stressed
cancer cell includes: Genistein (Cayman Chemical, Ann
Arbor, MI, USA), XIAP inhibitor Embelin (Sigma-Aldrich,
St. Louis, MO, USA), MDM2 inhibitor boranyl-chalcone
(Calbiochem, La Jolla, CA, USA), General caspase inhibitor
Z-VAD-fmk (MP Biochemical, Aurora, Ohio, USA),
Actinomycin D and Cycloheximide (Sigma-Aldrich).
Live cell staining and imaging
Cells were seeded on a glass coverslip (Marienfeld,
Lauda-Ku¨nigahofen, Germany) in dish (Nunc, 60 mm).
Mitochondria was stained with 50 nM MitoTracker Red
CMXRos (Invitrogen, Eugene, Oregon, USA) for 45 -
minutes and nuclei were stained with 250 ng/ml Hoechst
33342 (Invitrogen) for 15 minutes. Then the cells were
washed three times with PBS and then cultured in CO2-
independent medium (Invitrogen) on a thermo-cell culture
FCS2 chamber (Bioptechs, Butler, PA,USA) that was
mounted onto adapter in the stage of an inverted fluor-
escence microscope Cell Observer (Carl Zeiss, Jena,
Germany). Cell morphology was visualized by differential
interference contrast (DIC) channel. Mitochondria and
nucleuses were detected by fluorescence excited at 561
and 405 nm respectively. Cell images were captured with
a monochromatic CoolSNAP FX camera (Roper Scientific,
Pleasanton, CA, USA) with x63 numerical aperture (NA)
1.4 Plan-Apochromat objective (Carl Zeiss), and analyzed
by AxioVision 4.2 software (Carl Zeiss).
MTT cell viability assay
Cells were seed for 24 h on flat bottomed plates
(Nunc, 96 well). After different treatments, 16 μL of
Table 1 Primer sequences for target genes
Gene symbol Forward Primer (5’ to 3’) Product size
Reverse Primer (5’ to 3’c
BCL2 ATGTCCAGCCAGCTGCACCTGAC 319 bp
GCAGAGTCTTCAGAGACAGCCAGG
MDM2 CCCTGGTTAGACCAAAGCCAT 190 bp
GGCACGCCAAACAAATCTCC
GAPDH CATGAGAAGTATGACAACAGCCT 113 bp
AGTCCTTCCACGATACCAAAGT
XIAP GGGTTCAGTTTCAAGGACATTAAG 182 bp
CGCCTTAGCTGCTCTTCAGTAC
ATF3 AACCTGACGCCCTTTGTCAAG 138 bp
TACCTCGGCTTTTGTGATGGA
BAX GATGCGTCCACCAAGAAGCT 170 bp
CGGCCCCAGTTGAAGTTG
MCL1 TAAGGACAAAACGGGACTGG 137 bp
ACCAGCTCCTACTCCAGCAA
TP53 GAGGTTGGCTCTGACTGTACC 133 bp
TCCGTCCCAGTAGATTACCAC
CREB1 TTAACCATGACCAATGCAGCA 140 bp
TGGTATGTTTGTACGTCTCCAGA
PUMA GACCTCAACGCACAGTACGAG 98 bp
AGGAGTCCCATGATGAGATTGT
NOXA ATGCCTGGGAAGAAGGCGC 164 bp
CAGGTTCCTGAGCAGAAGAGT
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ide (MTT) reagent (5 mg/ml, Sigma-Aldrich) was added to
each well and incubated at 37°C for 3 h. After incubation,
culturing medium was aspirated and 120 μl DMSO
(Sigma-Aldrich) was added to each well for 10 minutes’
incubation at room temperature. Absorbance was measured
at a wavelength of 570 nm (reference wavelength 650 nm)
by SpectraMax 250 microplate reader (Molecular Devices
Corp, Concord, ON, Canada).
BrdU cell proliferation assay
The cell proliferation ELISA, BrdU kit (Roche) was used
according to the manufacturer’s instructions. Cells were
seeded into 96-well plates (5 × 103 cells / well) and treat-
ments were added the next day. After each treatment, cells
were labeled with a 10 mM BrdU solution (5′bromo-2′
deoxyuridine) in culture medium and incubated for an
additional 48 h at 37°C. The medium was then replaced
with 100 ul Fixative/Denaturing solution and incubate for
30 minutes at room temperature. Anti-BrdU Antibody in
1:1000 dilutions was added to each well and the plates
were incubated at room temperature for 1 h. After three
washing steps, peroxidase-substrate color development
solution (100 μl) was added to each well and the color
reaction was stopped after 10 minutes with 25 μl 1 M
H2SO4. Absorbance of samples was measured at 370 nm
(reference wavelength 492 nm).
LDH Cytotoxicity Assay
The cell death LDH cytotoxicity detection kit (Roche) was
used according to the manufacturer’s instructions Briefly,
cells (1 × 104/well) were seeded in 96-well plates in 100 μl
of medium and incubated at 37°C for 24 h before treat-
ment. The maximum LDH release (high control) from cells
was determined by the addition of 2% 100 ul Triton X-100
(Sigma-Aldrich), followed by incubation at 37°C for 1 h.
The minimum LDH release was determined from un-
treated cells. After centrifugation at 200 g, supernatants of
samples with different treatments were transferred to a
new 96-well plate, and the reaction mixture from the kit
was added. After incubate for 30 minutes at room
temperature, absorbance at 490 nm (reference wavelength
620 nm) was recorded using microplate reader. ABS
(absorbance) experiment = (mean absorbance from the
treated cells) - (absorbance from blanks); ABS low = (mean
absorbance from low control, untreated cells) - (absorbance
from blanks); ABS high = (mean absorbance from high
control, Triton X-100 treated cells) - (absorbance from
blanks); the percentage of cytotoxicity was calculated as:
(Abs experiment – Abs low)/(Abs high – Abs low).
Quantitative Real-Time PCR
RNA was extracted using the RNeasy Mini Kit
(Qiagen) according to the manufacturer’s protocol. RNAconcentrations were measured spectrophotometrically.
First-strand cDNA was synthesized from 0.1 μg RNA
template using Reverse Transcriptase Polymerase Chain
Reaction. RT-qPCR amplifications were conducted on
BioRad iQ™5 Multicolor Real-time PCR Detection System
(Biorad), using SYBR® Green qPCR Supermix (Invitrogen).
Triplicate reactions were performed for each sample, both
for target and reference gene. The expression level of each
gene was determined by absolute quantification method.
First, the absolute value of each gene was determined by
standard curve. In each sample, the value of each target
gene was divided by the value of GAPDH reference gene
for normalization. The normalized data were expressed as
normalized mRNA level (the ratio of target gene level to
reference gene level). The Primers used for RT-qPCR are
listed in Table 1.
Western blot
Proteins collected from cell lysate were separated on a
10-15% SDS-PAGE gel and then transferred onto the
Immun-Blot PVDF membrane (Biorad) using semi-dry
transfer system (Biorad). After blocking, membrane was
incubated overnight at 4°C with 1:1000 primary antibodies
(anti-caspase 3, anti-PARP antibody from Cell Signaling,
Beverly, MA USA; anti-caspase 7, anti-caspase 9 and
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CA, USA). After washing three times with TBST, the
membrane was incubated in corresponding horseradish
peroxidase- conjugated secondary antibody (Bio-Rad,
Hercules, CA, USA) at 1:5000 dilution for another 1 h.
The excessive antibody was washed away three times
with TBST and signal was developed with ECL western
blotting detection system (Amersham Biosciences).
Annexin V/ Propidium Iodide Assay
After each treatment, cells were collected by trypsinization
and washed with chilled PBS. The cells were stained with
an Alexa Fluor® 488 Annexin V/Dead Cell Apoptosis Kit
(Invitrogen, Eugene, Oregon, USA) according to manufac-
turer’s instruction. Briefly, cell density was determined
and 1×106 cells were suspended in 1 ml 1× annexin bind-
ing buffer, followed by addition with 10 ul Alexa Fluor® 488
Annexin V (component A) and 2 ul 100 μg/ml propidium
iodide (component B) in the dark, at room temperature for
5 minutes, and immediately analyzed by flow cytometry
(Cytomics FC500, Beckman Coulter, CA, USA). Cells
Annexin V-positive/ PI-negative were considered as
early apoptotic, cells doubly positive as late apoptotic or
necrotic.
Trypan Blue Dye Exclusion Assay
Cells were washed with PBS twice and detached using
0.25% /EDTA Trypsin (Gibco). Cells were collected by
centrifuge at 200 g for 5 minutes and the supernatant
was discarded. The pellet was re-suspended in 1 ml PBS,
and 1 part of 0.4% trypan blue (Gibco) was mixed with 1
part cell suspension. 10ul trypan blue/cell mixture was
added to hemacytometer (Hausser Scientific, Horsham,
PA, USA) for quantification. The unstained (viable) and
stained (nonviable) cells were counted separately.
Cleaved-Caspase 3 Immunostaining
Cells (1×106/mL) were collected and fixed in 4% para-
formaldehyde (Sigma-Aldrich) for 10 minutes at 37°C,
following by permeabilization with 0.1% (v/v in fixative)
Triton X-100 (Sigma-Aldrich) for 30 minutes at room
temperature. After three times’ rinse with incubation
buffer (0.5% BSA in PBS) by centrifuge, cells were incu-
bated with 1:1600 rabbit anti-cleaved caspase-3 IgG (Cell
Signaling, Beverly, MA) overnight at 4°C. After rinsing
three times, cells were incubated with 1:1000 Alexa
Fluor® 488-conjugated goat anti-rabbit IgG (Invitrogen,
Eugene, Oregon, USA) solution with 250 ng/ml Hoechst
33342 (Invitrogen) for 1 h at room temperature. Then
cells were rinsed with incubation buffer and collected by
centrifuge. Cell pellet was re-suspended in 0.1 ml Anti-fade
Buffer (Invitrogen). 0.01 ml of suspended cells was spread
onto slides for fluorescence microscopy analysis.Statistical analysis
Each experiment was repeated three times for consistency
of the result. The results were either expressed relative to
controls, or as percentages of the cell population (mean ±
SE, n = 3). IC50 value was calculated using GraphPad
Prism 5 software. Significance of the differences in
multiple mean values comparison was determined by
one-way ANOVA when there is only one variable. Two-
way ANOVA was used when there were two variables and
P < 0.05 was considered to be statistically significant.
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